Skip to main content
4DMEDICAL LIMITED logo

4DMEDICAL LIMITED — Investor Relations & Filings

Ticker · 4DX ISIN · AU0000095416 LEI · 9845000A8F12A6A6FD75 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 546 across all filing types
Latest filing 2025-01-23 Capital/Financing Update
Country AU Australia
Listing ASX 4DX

About 4DMEDICAL LIMITED

https://4dmedical.com/

4DMedical Limited develops non-invasive respiratory imaging solutions centered on its proprietary XV Technology. This platform utilizes advanced algorithms to transform standard X-ray sequences into four-dimensional quantitative data, visualizing regional lung function in motion. The flagship XV Lung Ventilation Analysis Software (XV LVAS) provides clinicians with detailed maps of airflow distribution throughout the respiratory cycle, facilitating the early detection and monitoring of chronic conditions such as COPD, asthma, and interstitial lung disease. By providing objective, high-resolution insights into lung ventilation without the limitations of traditional pulmonary function tests, the company's cloud-based diagnostic tools aim to improve clinical workflows and patient management. The integration of artificial intelligence further enhances its capability to deliver precise, automated lung tissue analysis.

Recent filings

Filing Released Lang Actions
4DMedical progresses to a commercial agreement with Qscan 2 pages 200.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 24 January 2025 from 4DMedical Limited regarding a commercial agreement with Qscan. It discusses a business development and commercial contract but contains no financial statements, regulatory certifications, voting results, or detailed financial data. The content is a corporate update about a commercial agreement rather than a financial report, earnings release, or regulatory filing. It is not a report publication announcement since it does not mention any report being published or attached. The document fits best under Capital/Financing Update (CAP) as it relates to a commercial agreement and business development involving the company's products and services.
2025-01-23 English
Application for quotation of securities - 4DX 7 pages 20.2KB
Share Issue/Capital Change Classification · 95% confidence The document is an Appendix 2A form, which is a standard application for quotation of securities on the ASX (Australian Securities Exchange). It details the issuance and quotation of securities under an employee incentive scheme, including the number of securities, issue date, and other listing rule requirements. There is no financial performance data, earnings information, or management discussion. The document is a formal announcement related to capital changes, specifically the quotation of new shares issued under an employee incentive plan. This fits the category of Share Issue/Capital Change (SHA). The document length is 6540 characters, which is sufficient to contain detailed information about the share issue rather than just a brief announcement. Therefore, the classification is SHA with high confidence.
2025-01-23 English
Notification regarding unquoted securities - 4DX 7 pages 22.3KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and contains detailed information about the issuance of unquoted securities under an employee incentive scheme, including performance rights and options. It includes specifics such as security codes, issue dates, numbers of securities issued, and mentions key management personnel involved. The document is a formal notification to the ASX regarding securities issuance, which aligns with announcements about share issues or capital changes. There is no indication that this is a full financial report, audit, or management discussion. The content fits the category of announcements regarding new share issues or capital changes rather than a report or presentation. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length (8224 characters) and detailed issuance data support this classification with high confidence.
2025-01-16 English
Application for quotation of securities - 4DX 8 pages 24.7KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and details the application for quotation of securities issued under an employee incentive scheme by 4DMedical Limited. It includes specifics about the securities, issue dates, number of securities, and mentions that the securities are being issued in consideration of director services. The document is a formal application to the ASX for quotation of securities, which is a capital market activity related to share issuance and listing. It is not a financial report, earnings release, or management discussion. It is not a report publication announcement or a certification. The document fits the category of announcements regarding new share issues or capital changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length is sufficient and contains detailed information about the securities issued and their quotation application, supporting a high confidence classification.
2025-01-16 English
Change of Director's Interest Notice 2 pages 238.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities held by a director, including acquisitions and disposals of shares and performance rights. The content focuses on insider share transactions by a company director, including dates, quantities, and nature of the transactions. There is no financial performance data, earnings information, or report publication. The document fits the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document length is 3575 characters, which is consistent with a detailed insider trading notice rather than a full financial report or announcement. Therefore, the correct classification is DIRS (Director's Dealing).
2025-01-16 English
Change of Director's Interest Notice 2 pages 238.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a change in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the change, and dates. This is a clear report of personal share transactions by a company director. The document length is 3587 characters, which is typical for such notices. There is no indication that this is an annual report, earnings release, or any other type of financial or regulatory filing. Therefore, the document fits the definition of Director's Dealing (DIRS).
2025-01-16 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.